IBN IBN
Company Profile ↓Company Overview
IBN (IBN) is a publicly traded company listed on with a market capitalization of $217.67B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 16.8% per year over the last five years.
Revenue has grown at a 18.1% CAGR over the past five years.
Trades at an undemanding P/E of 0.2.
Maintains a net profit margin of 24.3%.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Mar 2026 Revenue of $2.23T (+9.1% YoY); net profit $542.08B.
- Trailing 12 Months Year-on-year growth — revenue +9.1%, earnings +6.2%.
- 5-Year Trend Long-term compounding — revenue CAGR 18.1%, profit CAGR 16.8%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 18.11% |
| 1 Year: | 9.13% |
Compounded Profit Growth
| 5 Years: | 16.78% |
| 1 Year: | 6.23% |
Stock Price Performance
| 1 Year: | -7.68% |
| 6 Months: | +0.64% |
| 3 Months: | +17.81% |
| 1 Month: | +3.25% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)63.64 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Excellent profit margin of 24.3%.
- Compounding revenue at 18.1% over 5 years.
- Profit CAGR of 16.8% over 5 years.
- Generates positive free cash flow.
CONS
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 356.14B | 346.05B | 352.93B | 357.42B | 383.66B |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - |
| Operating Income | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - |
| Interest Expense | - | 230.90B | 220.17B | 218.74B | 220.47B | 230.64B |
| Pretax Income | - | 195.57B | 191.26B | 178.24B | 208.13B | 213.74B |
| Tax Provision | - | 51.01B | 48.08B | 43.43B | 51.32B | 50.97B |
| Net Income | - | 135.58B | 133.57B | 125.38B | 147.55B | 154.40B |
| Diluted EPS | - | 37.42 | 36.84 | 34.58 | 40.72 | 42.58 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | - | 1.36T | 1.61T | 2.05T | 2.23T |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - |
| Operating Income | - | - | - | - | - |
| EBITDA | - | - | - | - | - |
| Interest Expense | - | 505.43B | 741.08B | 890.28B | 890.29B |
| Pretax Income | - | 354.61B | 615.08B | 730.04B | 773.20B |
| Tax Provision | - | 117.93B | 154.28B | 184.35B | 193.84B |
| Net Income | - | 340.37B | 442.56B | 510.29B | 542.08B |
| Diluted EPS | - | 95.68 | 123.92 | 142.28 | 149.54 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Total Assets | 19.58T | 23.64T | 26.42T | 29.14T |
| Current Assets | - | - | - | - |
| Cash & Equivalents | 1.64T | 1.90T | 2.38T | 2.90T |
| Inventory | - | - | - | - |
| Receivables | 151.10B | 208.55B | 238.38B | 236.60B |
| Total Liabilities | 17.37T | 20.94T | 23.13T | 25.35T |
| Current Liabilities | - | - | - | - |
| Long Term Debt | 1.74T | 1.84T | 1.81T | 1.83T |
| Total Debt | 1.84T | 2.01T | 2.04T | 2.08T |
| Total Equity | 2.14T | 2.56T | 3.14T | 3.63T |
| Shares Outstanding | 6.98B | 7.02B | 7.12B | 7.16B |
Cash Flows (Annual)
Figures in USD.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -37.71B | 1.57T | 1.23T | 673.25B |
| Investing Cash Flow | - | -680.05B | -1.46T | -772.88B | -130.14B |
| Financing Cash Flow | - | 247.91B | 137.65B | 55.89B | -46.61B |
| Capital Expenditure | - | -24.68B | -36.79B | -47.70B | -37.30B |
| Free Cash Flow | - | -62.39B | 1.54T | 1.18T | 635.95B |
| Net Change in Cash | - | -469.86B | 251.18B | 511.06B | 496.51B |
Ratios (Annual)
Figures in %.
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | 25.1% | 27.5% | 24.9% | 24.3% |
| ROE % | - | 15.9% | 17.3% | 16.3% | 14.9% |
| ROCE % | - | - | - | - | - |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for IBN
ICICI Bank (NYSE:IBN) Breakout Setup Emerges as Trend and Consolidation Align - ChartMill
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxPMVpIdXZLMVB2NkNBQy04bVloU3VhbHh3V2N3cWZITGlYUjJydFBOc2R5a0prS3Z1WV94YlNuelBiZkZPUDQwUldkOHlBNWU0VWxkeURRcTlubU5FMkZVS05xUlpQSEJUYkxoR0hOQ1FNeGQ4MWppeGpUS3ZWSGw1cUR5cjh2Qm5Qd3cxbm…
Is IBN Undervalued? DCF Says Worth $40 - GuruFocus
<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOTjhSOHBwbk9NWEFORXoxNDBoYU1JZFdKTm5xcGdFTjQwTDVuYlU1N1gtNlM3M1Z6c2VRMWJZMjdyTm44Ynl0RmNVTm9nTUZ2VVNvVGkwQzRuTGdJeEpQX0IzV3F0Y0dSVzFFaU04T05iX1hXdjQ4eFEtSFRjcnRfMmItS1lNRmV3b3NJZ1…
Is ICICI Bank Limited (IBN) The Best Deep Value Stock to Invest in? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxNVW1Ud3NTWGQwX2hCUXhkaWx1MjA5dzBva2VydS1VYUdPNTVnTGFlcXJ1N1A2OWVtZWFFdGlEaEZwWEkxZW1HZUdUY3dYV3YzNTc3UVFpaUhWX1pWOTBBTkpFQ2JwaDFscHVkYk02eUJSNkR3aG1OT0loRVlmOTZpZXItZjJEbWI0QTlzNm…
ICICI Bank (NYSE: IBN) gets RBI approval for two-year director reappointment - Stock Titan
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxPNFJpUmxJXzcxZlZxNnR4VVlNRV8ta0hMdXZERmVkSWd3aExWa3BQZndVMjZPemgwbjJScUE5Y201MTlnd2RMS01VdUpZM3JKdC1yZkJ3NmlsRmlfWUZhWW1JTUt0d0lkQ3p3cUs2QWx5TUIxdDNtTWxtWnBkWXBUbzc1OEdNOTdFVGlBaU…
ICICI Bank (NYSE:IBN) Stock Rating Upgraded by Sanford C. Bernstein - MarketBeat
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxQMW9MaHhyQzQ4WVprYThjSEtPamxIQ0RQYzdlMHZyM056OUFaUkJhRHBacHJ2NWI2WXBBSXB3VGZLblo4alhCTE9aRWM4a1NZZVhZSVpiWjhMb2RFNFo5UmxTSTRhLVg0MHRaZGs2Y0lOT2JYNVVrRTRQUzhqNUNBVjBBekVLLXEzcFBXX2…
Responsive Playbooks and the IBN Inflection - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMivwFBVV95cUxOQUl2UjhUc0NNNjZoZGpBV1ZWbG43b1BBWV8yMzIyT3J2dE1BLUV0WVBQQkhjYTlENThwc2hoTDJadEtDczdmWHRlWkhod205Z3AyTDVZRUFWOGRxR2NnMUFXamhfblkwSHhFS016S1RYMHNLNXFTclRQTHJnN1RJTF91LVZHNzFGRGtFR2…
IBN — Frequently Asked Questions
What is the current share price of IBN?
As of 2026-08-05 17:25 PDT, IBN trades at $30.40 on NASDAQ/NYSE. Its 52-week range is $24.99 to $33.05.
What is the market capitalisation of IBN?
IBN has a market capitalisation of $217.67B on NASDAQ/NYSE.
What is the P/E ratio of IBN?
IBN trades at a trailing price-to-earnings (P/E) ratio of 0.20. Its price-to-book (P/B) ratio is 0.06.
What is the return on equity (ROE) of IBN?
IBN has a return on equity (ROE) of 14.93%.
Is IBN a good stock to buy?
This page provides a data-driven analysis of IBN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.